P425-0618 Screening compound: N-[(furan-2-yl)methyl]-5H,6H,7H,8H-imidazo[1,2-a]pyridine-2-carboxamide

P425-0618 Screening compound: N-[(furan-2-yl)methyl]-5H,6H,7H,8H-imidazo[1,2-a]pyridine-2-carboxamide
P425-0618 Screening compound: N-[(furan-2-yl)methyl]-5H,6H,7H,8H-imidazo[1,2-a]pyridine-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P425-0618
N-[(furan-2-yl)methyl]-5H,6H,7H,8H-imidazo[1,2-a]pyridine-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P425-0618

Molecular Formula

C13H15N3O2 (C13 H15 N3 O2)

Compound Name

N-[(furan-2-yl)methyl]-5H,6H,7H,8H-imidazo[1,2-a]pyridine-2-carboxamide

IUPAC name

N-[(furan-2-yl)methyl]-5H6H7H8H-imidazo[12-a]pyridine-2-carboxamide

SMILES

O=C(c1cn(CCCC2)c2n1)NCc1ccco1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

245.28

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

1.605

Distribution Coefficient, logD

1.604

Water Solubility, LogSw

-1.72

Polar Surface Area

45.276

Acid Dissociation Constant (pKa)

12.51

Base Dissociation Constant (pKb)

4.57

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

38.50

P425-0618 in Drug Discovery

Included in Screening Libraries

CNS MPO Library (28609 compounds)

Fragments Library (11262 compounds)

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

Soluble Diversity Library (15920 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Indoleamine 2,3-dioxygenase 1 Focused Library (5816 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Immune system
Structure:
  • Fragments
  • Cyclic compounds
Targets:
  • GPCR
  • Others
Mechanism of action:
  • Receptor's ligands
  • PPI modulators

References: we are preparing a list of scientific research reports with P425-0618 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P425-0618?
Check Price and Availability of P425-0618, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P425-0618 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P425-0618
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P425-0618
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P425-0618 available by request